Results 21 to 30 of about 1,078,518 (304)

Cost-utility analysis of bariatric surgery compared with conventional medical management in Germany: a decision analytic modeling

open access: yesBMC Surgery, 2017
Background The objective was to evaluate cost-utility of bariatric surgery in Germany for a lifetime and 10-year horizon from a health care payer perspective.
Oleg Borisenko   +2 more
doaj   +1 more source

Medico-economic impact of thoracoscopy versus thoracotomy in lung cancer: multicentre randomised controlled trial (Lungsco01)

open access: yesBMC Health Services Research, 2023
Background Lungsco01 is the first study assessing the real benefits and the medico-economic impact of video-thoracoscopy versus open thoracotomy for non-small cell lung cancer in the French context.
Anne-Laure Soilly   +13 more
doaj   +1 more source

An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations

open access: yesFrontiers in Public Health, 2021
Economic evidence is increasingly being used for informing health policies. However, the underlining principles of health economic analyses are not always fully understood by non-health economists, and inappropriate types of analyses, as well as ...
Hugo C. Turner   +9 more
doaj   +1 more source

Cost-utility analysis of an implant treatment in dentistry [PDF]

open access: yesBMC Oral Health, 2021
Abstract Background When dealing with the replacement of one missing tooth, the patient has the option of choosing between different types of treatment interventions. Several important factors play a role in his decision-making process, including his limited financial means and his efforts to solve the problem of missing
Johana Losenická   +2 more
openaire   +3 more sources

A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma

open access: yesBMC Ophthalmology, 2012
Background Economic viability of treatments for primary open-angle glaucoma (POAG) should be assessed objectively to prioritise health care interventions.
Bozzani Fiammetta Maria   +3 more
doaj   +1 more source

Decision Rules in Cost-Utility Analysis of Health Technologies

open access: yesWalailak Journal of Science and Technology, 2021
This review identified 4 distinct decision rules used in the cost-utility analysis of health technologies: threshold incremental cost-effectiveness ratio (ICER), league table, decision making (DM) plane, and linear programming.
Udomsak SAENGOW
doaj   +3 more sources

Cost-utility analysis of thrombolytic therapy [PDF]

open access: yesEuropean Heart Journal, 1991
An analysis of the cost-effectiveness of thrombolytic therapy was performed, based on 3- to 5-year follow-up data, from 533 patients randomized to receive conventional therapy or intracoronary streptokinase. At the 3-year follow-up, mortality was 22% in the former group and 14% after thrombolysis.
M L, Simoons, J, Vos, L L, Martens
openaire   +2 more sources

Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis

open access: yesHealth Technology Assessment, 2023
Background Severe acute respiratory syndrome coronavirus 2 is the virus that causes coronavirus disease 2019. Over six million deaths worldwide have been associated with coronavirus disease 2019.
Metry Andrew   +7 more
doaj   +1 more source

Cost-effectiveness of tumor necrosis factor-alpha inhibitors: a systematic review and meta-analysis of cost-utility studies

open access: yes, 2023
To systematically review the cost-utility evidence of TNF-a-i treatment for rheumatoid arthritis (RA) and to estimate the pooled incremental net benefit (INBp).
Bhavani Shankara Bagepally (10717496)   +1 more
core   +1 more source

Economic evaluation of using pesticides to control cutaneous leishmaniasis in Isfahan

open access: yesJournal of Research in Pharmacy Practice, 2018
Objective: Pesticides have been used as the main part of the national cutaneous leishmaniasis control program for serveral years in Iran. However, the cost-effectiveness of this strategy has not been yet analyzed.
Ehsanallah Jafari   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy